Form D · Private Equity Fund
Allergy & ENT Management Holdings, LLC
New York, NY · CIK 0001966709
Offering snapshot reported Mar 1, 2023 · SEC filing
- Reported sold
- $16.4M Offering amount: $16.4M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 15, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 1, 2023 | Initial | $16,400,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-474528
Source: Form D, filed Mar 1, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jorge Alderete | Director |
| Jonathan Kelemen | Director |
| Andrew Marolda | Director |
| Cameron Perkins | Director |
| Enrique Quintero | Director |
| Kelvin Shaw | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
530 Fifth Avenue 23 Rd Floor
New York, NY, 10036
New York, NY, 10036